NCT04865159View on ClinicalTrials.gov

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

May 2, 2023

Study Completion Date

May 2, 2023

Conditions
Advanced Solid Tumor
Interventions
DRUG

Tipifarnib

Cardiac Safety of Tipifarnib

Trial Locations (3)

44718

Gabrail Cancer Center Research, Canton

78229

NEXT Oncology, San Antonio

78758

NEXT Oncology, Austin

Sponsors
All Listed Sponsors
lead

Kura Oncology, Inc.

INDUSTRY